By Adria Calatayud 
 

RELX PLC said Thursday that revenue from its exhibitions business fell 70% for the first nine months of the year, but that its three largest business areas continued to gradually improve during the third quarter.

The FTSE 100 information and analytics group said it now expects exhibitions revenue for the full year to be between 330 million and 360 million pounds ($433.9 million-$473.3 million), and costs for the unit to be between GBP530 million and GBP540 million excluding one-off costs related to restructuring and cancellations.

The company behind the Lancet medical journal and the London Book Fair said the outlook for its three largest businesses--scientific, technical and medical, risk and business-analytics, and legal--remains unchanged.

For the first nine months of the year, underlying revenue rose 2% at RELX's scientific, technical and medical business, 3% at its risk and business-analytics unit and 1% at its legal division.

 

Write to Adria Calatayud at adria.calatayud@dowjones.com

 

(END) Dow Jones Newswires

October 22, 2020 02:35 ET (06:35 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
RELX (NYSE:RELX)
Historical Stock Chart
From Nov 2020 to Dec 2020 Click Here for more RELX Charts.
RELX (NYSE:RELX)
Historical Stock Chart
From Dec 2019 to Dec 2020 Click Here for more RELX Charts.